Genmab — Januar 2017
-
@Sukkeralf Med dagens udvikling varer det ikke længe før du igen får muligheden for at sælge Exel til kurs 18
-
-
God morgen.
-
Godmorgen
-
Apropos vores snak i går aftes:
"Genmab and Janssen now believe that Darzalex helps to activate the immune system, thus enhancing the efficacy of immuno-oncology agents such as PD-1 inhibitors". -
"The speed at which Janssen and Bristol-Myers Squibb have formed their collaboration is testament to the potential of this combination, says van de Winkel, who confirms that Roche will also soon initiate solid tumour studies of Darzalex in combination with its PD-L1 inhibitor Tecentriq"
. -
Ja..Tak for link jkj.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind